Development of an Automated AAV8 Capsid Titer Assay on Gyrolab® xPand Immunoassay Platform

Поделиться
HTML-код
  • Опубликовано: 16 май 2024
  • "Development of an Automated AAV8 Capsid Titer Assay on Gyrolab® xPand Immunoassay Platform." Presented by Matthew Lotti, Sr. Research Associate II, Analytical Development Team, Ultragenyx Pharmaceutical.
    BioProcess International Ask the Expert 2021.
  • НаукаНаука

Комментарии •